ANI Pharmaceuticals to Acquire Alimera Sciences for $381 Million

ANI Pharmaceuticals, Inc. (ANIP) and Georgia-based biopharmaceutical company Alimera Sciences, Inc. (ALIM) on June 24, 2024, entered into a definitive agreement under which ANI will acquire Alimera for $381 million.

Deal Structure:

As per the agreement, ANI will acquire Alimera for $5.50 per share in cash, representing a premium of 74.6% from the stock’s last close.

Please subscribe for free or login to your InsideArbitrage account to access this article.